20. Vaccine–Preventable Diseases

Table 20.2: Estimated Number of Deaths in the Absence of Vaccination, Deaths from Vaccine-preventable Diseases, and Deaths Averted by Vaccination, All Ages, by Region and Vaccine, 2001 (thousands)

Estimated Number of Deaths in the Absence of Vaccination, Deaths from Vaccine-preventable Diseases, and Deaths Averted by Vaccination, All Ages, by Region and Vaccine, 2001 (thousands)
DiseaseTotalHigh incomeEast Asia and the PacificEurope and Central AsiaLatin America and the CaribbeanMiddle East and North AfricaSouth AsiaSub-Saharan Africa
Diphtheria
If noSFTRET  vaccination78 3 28 4  8 5 21   10
EstimatedSFTRET  deaths5<1  1<1 <1<1  3    1
DeathsSFTRET  averted73 3 27 4  8 5 18    9
Pertussis
If noSFTRET  vaccination1,343 7377 413893428  296
EstimatedSFTRET  deaths301<1  3<1  6 8108  176
DeathsSFTRET  averted1,042 7374 413285320  120
Tetanus
If noSFTRET  vaccination936<1110<1 2023543  239
EstimatedSFTRET  deaths293<1 27<1  1 4140  121
DeathsSFTRET  averted643<1 83<1 1919403  118
Poliomyelitis
If noSFTRET  vaccination52 1 15 1  3 4 17   11
EstimatedSFTRET  deathsa<1<1 <1 0  0 0  0    0
DeathsSFTRET  averted51n.a. 15 1  3 4 17   11
Measles
If noSFTRET  vaccination2,000 630136  6555671,025
EstimatedSFTRET  deathsb676<1 77 4 <1 7239  348
DeathsSFTRET  averted1,237 522928  640351  578
Hib
If noSFTRET  vaccination468<1 28 2  914199  216
EstimatedSFTRET  deaths463<1 28 2  514199  215
DeathsSFTRET  averted5<1 <1<1  4<1 <1    1
Hepatitis B
If noSFTRET  vaccination6003437036 1117 75   58
EstimatedSFTRET  deaths6003437036 1117 75   58
DeathsSFTRET  avertedc<1<1 <1<1 <1<1 <1   <1
Yellow fever
If noSFTRET  vaccination63n.a.n.a.n.a.  8n.a.n.a.   54
EstimatedSFTRET  deaths30n.a.n.a.n.a.  6n.a.n.a.   24
DeathsSFTRET  averted33n.a.n.a.n.a.2n.a.n.a.   30

Source:

n.a. = not available.

Note: Totals may not add due to rounding.

a. Primarily deaths at older ages caused by delayed effect of poliomyelitis in childhood.

b. See text for discussion of uncertainty regarding measles estimates. The values shown here are an updated version of the 2001 estimates.

c. Deaths averted to date from the use of the hepatitis B vaccine in infant immunization programs are minimal, largely because of the long time period (20 to 40 years) to see mortality effects.

< Back to Chapter Summary Page

Chapter Sections